Tofacitinib (CP-690550,Tasocitinib) 10mM (in 1mL DMSO) | 99.15% APEXBIO TECHNOLOGY LLC Janus kinase inhibitor Chromatin/Epigenetics|JAK More Information Supplier Page × Tofacitinib (CP-690550,Tasocitinib)
Tofacitinib (CP-690550,Tasocitinib) 10mg | 99.15% APEXBIO TECHNOLOGY LLC Janus kinase inhibitor Chromatin/Epigenetics|JAK More Information Supplier Page × Tofacitinib (CP-690550,Tasocitinib)
Tofacitinib (CP-690550,Tasocitinib) 50mg | 99.15% APEXBIO TECHNOLOGY LLC Janus kinase inhibitor Chromatin/Epigenetics|JAK More Information Supplier Page × Tofacitinib (CP-690550,Tasocitinib)
TG101348 (SAR302503) 10mg | 99.39% APEXBIO TECHNOLOGY LLC JAK-2 inhibitor,potent and selective Chromatin/Epigenetics|JAK More Information Supplier Page × TG101348 (SAR302503)
TG101348 (SAR302503) 25mg | 99.39% APEXBIO TECHNOLOGY LLC JAK-2 inhibitor,potent and selective Chromatin/Epigenetics|JAK More Information Supplier Page × TG101348 (SAR302503)
TG101348 (SAR302503) 50mg | 99.39% APEXBIO TECHNOLOGY LLC JAK-2 inhibitor,potent and selective Chromatin/Epigenetics|JAK More Information Supplier Page × TG101348 (SAR302503)
AZD1480 5mg | 98.01% APEXBIO TECHNOLOGY LLC JAK2 inhibitor,ATP-competitive and novel Chromatin/Epigenetics|JAK More Information Supplier Page × AZD1480
AZD1480 10mg | 98.01% APEXBIO TECHNOLOGY LLC JAK2 inhibitor,ATP-competitive and novel Chromatin/Epigenetics|JAK More Information Supplier Page × AZD1480
TG101348 (SAR302503) 5mg | 99.39% APEXBIO TECHNOLOGY LLC JAK-2 inhibitor,potent and selective Chromatin/Epigenetics|JAK More Information Supplier Page × TG101348 (SAR302503)
TG101348 (SAR302503) Evaluation Sample | 99.39% APEXBIO TECHNOLOGY LLC JAK-2 inhibitor,potent and selective Chromatin/Epigenetics|JAK More Information Supplier Page × TG101348 (SAR302503)